Clinical Trial Update: Omega-3 and Therapy Study for Depression [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating omega-3 fatty acids as an adjunct to therapy for depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: L. Eugene Arnold | Conditions: Depression | Phase 1 | Status: COMPLETED